The ALS Therapy Development Institute (ALS TDI) is partnering with Unite Genomics, a leading healthcare data analytics company, to integrate electronic.
Item 7.01 Regulation FD Disclosure.
On December 12, 2022, Black Diamond Therapeutics, Inc. issued a
press release entitled Black Diamond Therapeutics Announces Spinout of
Launchpad Therapeutics,. | December 12, 2022
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy.